We also discovered that inflammation-related genes (TNF-, IL-6, and IL-1b) showed no changes even after 5 weeks of EVs-Cas9-29b therapy in IMO- and Den-induced muscle atrophy which is coincidentally the endpoint of the treatments. The gene discussed is TNF; the disease is muscle atrophy.